These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 19274661)

  • 41. Genomics of Mycobacterium tuberculosis: old threats & new trends.
    Ahmed N; Hasnain SE
    Indian J Med Res; 2004 Oct; 120(4):207-12. PubMed ID: 15520478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of IS6110 in the evolution of Mycobacterium tuberculosis.
    McEvoy CR; Falmer AA; Gey van Pittius NC; Victor TC; van Helden PD; Warren RM
    Tuberculosis (Edinb); 2007 Sep; 87(5):393-404. PubMed ID: 17627889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hallmarks of mycolic acid biosynthesis: a comparative genomics study.
    Raman K; Rajagopalan P; Chandra N
    Proteins; 2007 Nov; 69(2):358-68. PubMed ID: 17600834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipoproteins of Mycobacterium tuberculosis: an abundant and functionally diverse class of cell envelope components.
    Sutcliffe IC; Harrington DJ
    FEMS Microbiol Rev; 2004 Nov; 28(5):645-59. PubMed ID: 15539077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A glimpse into the past and predictions for the future: the molecular evolution of the tuberculosis agent.
    Boritsch EC; Supply P; Honoré N; Seemann T; Stinear TP; Brosch R
    Mol Microbiol; 2014 Sep; 93(5):835-52. PubMed ID: 25039682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Gene inactivation in Mycobacterium tuberculosis and its use in tuberculosis control and prevention].
    Chacón O; Realpe T; Barletta RG; Robledo J
    Biomedica; 2004 Jun; 24 Supp 1():165-87. PubMed ID: 15495585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular detection, identification and drug resistance detection in Mycobacterium tuberculosis.
    Palomino JC
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):103-11. PubMed ID: 19416361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
    Dietrich J; Doherty TM
    APMIS; 2009 May; 117(5-6):440-57. PubMed ID: 19400867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microbiology. Chemical warfare and mycobacterial defense.
    Pieters J; Ploegh H
    Science; 2003 Dec; 302(5652):1900-2. PubMed ID: 14671281
    [No Abstract]   [Full Text] [Related]  

  • 50. Rv0901 from Mycobacterium tuberculosis, a possible novel virulent gene proved through the recombinant Mycobacterium smegmatis.
    Zhang L; Zhong Q; Bao L; Zhang Y; Gao L; Huang B; Zhang HD
    Jpn J Infect Dis; 2009 Jan; 62(1):26-31. PubMed ID: 19168955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular dissection of the biosynthetic relationship between phthiocerol and phthiodiolone dimycocerosates and their critical role in the virulence and permeability of Mycobacterium tuberculosis.
    Siméone R; Constant P; Malaga W; Guilhot C; Daffé M; Chalut C
    FEBS J; 2007 Apr; 274(8):1957-69. PubMed ID: 17371506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Host-pathogen interplay and the evolution of bacterial effectors.
    Stavrinides J; McCann HC; Guttman DS
    Cell Microbiol; 2008 Feb; 10(2):285-92. PubMed ID: 18034865
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The tuberculous diseases originating from different species of acid-fast bacilli.
    BOGEN E; FROMAN S; WILL D
    Calif Med; 1959 Feb; 90(2):117-20. PubMed ID: 13629345
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Persistent and dormant tubercle bacilli and latent tuberculosis.
    Zhang Y
    Front Biosci; 2004 May; 9():1136-56. PubMed ID: 14977534
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antagonists of Hsp16.3, a low-molecular-weight mycobacterial chaperone and virulence factor, derived from phage-displayed peptide libraries.
    Saha A; Sharma A; Dhar A; Bhattacharyya B; Roy S; Das Gupta SK
    Appl Environ Microbiol; 2005 Nov; 71(11):7334-44. PubMed ID: 16269776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overcoming the global crisis: "yes, we can", but also for TB ... ?
    Ottenhoff TH
    Eur J Immunol; 2009 Aug; 39(8):2014-20. PubMed ID: 19672895
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Large genomics datasets shed light on the evolution of the Mycobacterium tuberculosis complex.
    Chiner-Oms Á; Comas I
    Infect Genet Evol; 2019 Aug; 72():10-15. PubMed ID: 30822550
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Virulence factors of Mycobacterium tuberculosis].
    Maulén NP
    Rev Med Chil; 2011 Dec; 139(12):1605-10. PubMed ID: 22446709
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A microbiological revolution meets an ancient disease: improving the management of tuberculosis with genomics.
    Wlodarska M; Johnston JC; Gardy JL; Tang P
    Clin Microbiol Rev; 2015 Apr; 28(2):523-39. PubMed ID: 25810419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of virulence factors of pathogenic bacteria.
    Wu HJ; Wang AH; Jennings MP
    Curr Opin Chem Biol; 2008 Feb; 12(1):93-101. PubMed ID: 18284925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.